Sensitization of prostate carcinoma cells to Apo2L/TRAIL by a Bcl-2 family protein inhibitor

By Ray S.   Bucur O.   Almasan A.  

Apoptosis, Vol. 10, Iss. 6, 2005-12 ,pp. : 1411-1418

Springer Publishing Company

Access to resources Recommend Favorite

Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells

By Lippa Mara   Strockbine Laura   Le Tiep   Branstetter Daniel   Strathdee Craig   Holland Pamela  

Apoptosis, Vol. 12, Iss. 8, 2007-08 ,pp. : 1465-1478

Springer Publishing Company

Access to resources Recommend Favorite

Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade

By Reddy Rishindra   Yeow Wen-Shuz   Chua Alex   Nguyen Duc   Baras Aris   Ziauddin M.   Shamimi-Noori Susan   Maxhimer Justin   Schrump David   Nguyen Dao  

Apoptosis, Vol. 12, Iss. 1, 2007-01 ,pp. : 55-71

Springer Publishing Company

Access to resources Recommend Favorite

Induction of necrotic tumor cell death by TRAIL/Apo-2L

By Kemp T. J.   Kim J.-S.   Crist S. A.   Griffith T. S.  

Apoptosis, Vol. 8, Iss. 6, 2003-12 ,pp. : 587-599

Springer Publishing Company

Access to resources Recommend Favorite

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

By Almasan A.   Ashkenazi A.  

Cytokine and Growth Factor Reviews, Vol. 14, Iss. 3, 2003-06 ,pp. : 337-348

Elsevier

Access to resources Recommend Favorite